LAUSR

The principal indication for glaucoma drainage devices (GDDs) is usually glaucoma refractory to filtering surgery.[1] Currently, commonly available GDDs are either valved like the Ahmed glaucoma valve (AGV; New World Medical Inc., Rancho Cucamonga, CA, USA) or non‐valved GDDs like the Baerveldt glaucoma implant (BGI; Abbott Medical Optics, Abbott Park, IL, USA) and Aurolab aqueous drainage implant (AADI; Aurolab, Aravind Eye Hospital, Madurai, India), which have been shown to be safe and effective in both pediatric and adult populations. AADI has certain advantages over AGV. Since it is indigenously manufactured, it is highly cost‐effective when compared to AGV. Studies have shown that it has a higher success rate, achieves significantly lower intraocular pressure (IOP), and the patients require less number of anti‐glaucoma medications postoperatively. Some studies also indicate that the long‐term IOP control is better with AADI when compared to that with AGV.[1‐3]